Study of HS-20093 Versus Gemcitabine in Combination With Docetaxel in Treatment of Osteosarcoma After Previous Second-line Treatment Failure
Hansoh BioMedical R&D Company
Hansoh BioMedical R&D Company
M.D. Anderson Cancer Center
Brown University
Italian Sarcoma Group
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
Sarcoma Alliance for Research through Collaboration
Case Comprehensive Cancer Center